. Author manuscript; available in PMC: 2014 Sep 11.

Published in final edited form as: Cochrane Database Syst Rev. 2010 Aug 4;(8):CD007667. doi: 10.1002/14651858.CD007667.pub2

Table 5. Comparison 2: bromocriptine versus placebo: drinking days.

Study	Outcome	Experimental group (n=9 completed)	Control group (n=9 completed)	Statistic
Powell 1995	mean number of drinking days over the 6-month study	19.0 (no SD provided) (see note 1)	42.2 (no SD provided) (see note 1)	favours neither condition (see note 2)

SD = standard deviation

1. figures derived from data presented graphically (Powell 1995, p.467, fig 1); no SDs provided.

2. two-way ANOVA; comorbidity × medication: F_(4,89)=2.60; P<0.05; however, Tukey post-hoc tests did not indicate a statistically significant effect for AsPD/bromocriptine subgroup; completer analysis by trial investigators.